BHAT BALKRISHEN has a total of 33 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SWAYZE ERIC E, ROCHE INNOVATION CT COPENHAGEN AS and ISIS PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 26 | |
#2 | WIPO (World Intellectual Property Organization) | 7 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Heterocyclic compounds | |
#6 | Climate change mitigation in goods production | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Bhat Balkrishen | 33 |
#2 | Prakash Thazha P | 25 |
#3 | Swayze Eric E | 19 |
#4 | Griffey Richard H | 17 |
#5 | Allerson Charles | 17 |
#6 | Dande Prasad | 15 |
#7 | Eldrup Anne B | 9 |
#8 | Olsen David B | 5 |
#9 | Maccoss Malcolm | 5 |
#10 | Carroll Steven S | 4 |
Publication | Filing date | Title |
---|---|---|
WO2008094945A2 | Compounds and methods for modulating protein expression | |
US2009306178A1 | Conjugated double strand compositions for use in gene modulation | |
US2012165515A1 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | |
US2008146788A1 | Positionally modified siRNA constructs | |
WO2004003138A2 | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |